Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 USD | +8.00% | -2.80% | -66.06% |
Mar. 28 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | Top Midday Gainers | MT |
Financials (USD)
Sales 2024 * | 59.17M | Sales 2025 * | 88.09M | Capitalization | 31.56M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 0.53 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.36 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
7.15
x | Employees | 176 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.99% |
1 day | +8.00% | ||
1 week | -2.80% | ||
Current month | -32.69% | ||
1 month | -20.59% | ||
3 months | -51.50% | ||
6 months | -22.61% | ||
Current year | -66.06% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 2.43 | +8.00% | 13,103 |
24-04-19 | 2.25 | +0.45% | 10,089 |
24-04-18 | 2.24 | 0.00% | 91,870 |
24-04-17 | 2.24 | -4.27% | 41,073 |
24-04-16 | 2.34 | -6.40% | 30,260 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.06% | 31.56M | |
+25.46% | 659B | |
+25.41% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.68% | 215B | |
+7.86% | 210B | |
-6.75% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- CASI Stock